Neurology Diagnostic and Monitoring Devices Market (Device Type: Electroencephalogram (EEG) Systems, Magnetic Resonance Imaging (MRI) Systems, Computed Tomography (CT) Scanner, Position Emission Tomography (PET) System, Ultrasound Imaging Systems, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
Neurology Diagnostic and Monitoring Devices Market – Scope of Report
TMR’s report on the global neurology diagnostic and monitoring devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global neurology diagnostic and monitoring devices market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global neurology diagnostic and monitoring devices market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the neurology diagnostic and monitoring devices market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global neurology diagnostic and monitoring devices market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global neurology diagnostic and monitoring devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global neurology diagnostic and monitoring devices market.
The report delves into the competitive landscape of the global neurology diagnostic and monitoring devices market. Key players operating in the global neurology diagnostic and monitoring devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global neurology diagnostic and monitoring devices market profiled in this report.
Key Questions Answered in Global neurology diagnostic and monitoring devices Market Report
- What is the sales/revenue generated by neurology diagnostic and monitoring devices across all regions during the forecast period?
- What are the opportunities in the global neurology diagnostic and monitoring devices market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
The comprehensive report on the global neurology diagnostic and monitoring devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global neurology diagnostic and monitoring devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global neurology diagnostic and monitoring devices market.
- 1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Neurology Diagnostic and Monitoring Devices Market
- 4. Market Overview
- 4.1. Introduction
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Neurology Diagnostic and Monitoring Devices Market Analysis and Forecasts, 2017 - 2031
- 4.5. Porter’s Five Force Analysis
- 5. Key Insights
- 5.1. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
- 5.2. Key Vendor and Distributor Analysis
- 5.3. Evolving Trends in Medical Imaging Services
- 5.4. Winning Imperatives, by Key Players
- 5.5. Growing Adoption of Remote Monitoring Technology, by Medical Imaging Service Providers
- 5.6. Technological Advancements
- 6. Global Neurology Diagnostic and Monitoring Devices Market Analysis and Forecasts, By Device Type
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast By Device Type, 2017 - 2031
- 6.3.1. Electroencephalogram (EEG) Systems
- 6.3.2. Magnetic Resonance Imaging (MRI) Systems
- 6.3.3. Computed Tomography (CT) Scanner
- 6.3.4. Position emission tomography (PET) System
- 6.3.5. Ultrasound Imaging Systems
- 6.3.6. Others
- 6.4. Market Attractiveness By Device Type
- 7. Global Neurology Diagnostic and Monitoring Devices Market Analysis and Forecasts, By Indication
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast By Indication, 2017 - 2031
- 7.3.1. Neurodegenerative Disease
- 7.3.2. Epilepsy
- 7.3.3. Stroke
- 7.3.4. Others
- 7.4. Market Attractiveness By Indication
- 8. Global Neurology Diagnostic and Monitoring Devices Market Analysis and Forecasts, By End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast By End-user, 2017 - 2031
- 8.3.1. Hospitals and Surgery Centers
- 8.3.2. Neurology Centers
- 8.3.3. Ambulatory Care Centers
- 8.3.4. Diagnostic Laboratories & Imaging Centers
- 8.3.5. Research Laboratories & Academic Institutes
- 8.4. Market Attractiveness By End-user
- 9. Global Neurology Diagnostic and Monitoring Devices Market Analysis and Forecasts, By Region
- 9.1. Key Findings
- 9.2. Market Value Forecast By Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness By Country/Region
- 10. North America Neurology Diagnostic and Monitoring Devices Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast By Device Type, 2017 - 2031
- 10.2.1. Electroencephalogram (EEG) Systems
- 10.2.2. Magnetic Resonance Imaging (MRI) Systems
- 10.2.3. Computed Tomography (CT) Scanner
- 10.2.4. Position emission tomography (PET) System
- 10.2.5. Ultrasound Imaging Systems
- 10.2.6. Others
- 10.3. Market Value Forecast By Indication, 2017 - 2031
- 10.3.1. Neurodegenerative Disease
- 10.3.2. Epilepsy
- 10.3.3. Stroke
- 10.3.4. Others
- 10.4. Market Value Forecast By End-user, 2017 - 2031
- 10.4.1. Hospitals and Surgery Centers
- 10.4.2. Neurology Centers
- 10.4.3. Ambulatory Care Centers
- 10.4.4. Diagnostic Laboratories & Imaging Centers
- 10.4.5. Research Laboratories & Academic Institutes
- 10.5. Market Value Forecast By Country, 2017 - 2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Device Type
- 10.6.2. By Indication
- 10.6.3. By End-user
- 10.6.4. By Country
- 11. Europe Neurology Diagnostic and Monitoring Devices Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast By Device Type, 2017 - 2031
- 11.2.1. Electroencephalogram (EEG) Systems
- 11.2.2. Magnetic Resonance Imaging (MRI) Systems
- 11.2.3. Computed Tomography (CT) Scanner
- 11.2.4. Position emission tomography (PET) System
- 11.2.5. Ultrasound Imaging Systems
- 11.2.6. Others
- 11.3. Market Value Forecast By Indication, 2017 - 2031
- 11.3.1. Neurodegenerative Disease
- 11.3.2. Epilepsy
- 11.3.3. Stroke
- 11.3.4. Others
- 11.4. Market Value Forecast By End-user, 2017 - 2031
- 11.4.1. Hospitals and Surgery Centers
- 11.4.2. Neurology Centers
- 11.4.3. Ambulatory Care Centers
- 11.4.4. Diagnostic Laboratories & Imaging Centers
- 11.4.5. Research Laboratories & Academic Institutes
- 11.5. Market Value Forecast By Country, 2017 - 2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Device Type
- 11.6.2. By Indication
- 11.6.3. By End-user
- 11.6.4. By Country
- 12. Asia Pacific Neurology Diagnostic and Monitoring Devices Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast By Device Type, 2017 - 2031
- 12.2.1. Electroencephalogram (EEG) Systems
- 12.2.2. Magnetic Resonance Imaging (MRI) Systems
- 12.2.3. Computed Tomography (CT) Scanner
- 12.2.4. Position emission tomography (PET) System
- 12.2.5. Ultrasound Imaging Systems
- 12.2.6. Others
- 12.3. Market Value Forecast By Indication, 2017 - 2031
- 12.3.1. Neurodegenerative Disease
- 12.3.2. Epilepsy
- 12.3.3. Stroke
- 12.3.4. Others
- 12.4. Market Value Forecast By End-user, 2017 - 2031
- 12.4.1. Hospitals and Surgery Centers
- 12.4.2. Neurology Centers
- 12.4.3. Ambulatory Care Centers
- 12.4.4. Diagnostic Laboratories & Imaging Centers
- 12.4.5. Research Laboratories & Academic Institutes
- 12.5. Market Value Forecast By Country, 2017 - 2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Device Type
- 12.6.2. By Indication
- 12.6.3. By End-user
- 12.6.4. By Country
- 13. Latin America Neurology Diagnostic and Monitoring Devices Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast By Device Type, 2017 - 2031
- 13.2.1. Electroencephalogram (EEG) Systems
- 13.2.2. Magnetic Resonance Imaging (MRI) Systems
- 13.2.3. Computed Tomography (CT) Scanner
- 13.2.4. Position emission tomography (PET) System
- 13.2.5. Ultrasound Imaging Systems
- 13.2.6. Others
- 13.3. Market Value Forecast By Indication, 2017 - 2031
- 13.3.1. Neurodegenerative Disease
- 13.3.2. Epilepsy
- 13.3.3. Stroke
- 13.3.4. Others
- 13.4. Market Value Forecast By End-user, 2017 - 2031
- 13.4.1. Hospitals and Surgery Centers
- 13.4.2. Neurology Centers
- 13.4.3. Ambulatory Care Centers
- 13.4.4. Diagnostic Laboratories & Imaging Centers
- 13.4.5. Research Laboratories & Academic Institutes
- 13.5. Market Value Forecast By Country, 2017 - 2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Device Type
- 13.6.2. By Indication
- 13.6.3. By End-user
- 13.6.4. By Country
- 14. Middle East & Africa Neurology Diagnostic and Monitoring Devices Market Analysis and Forecast
- 14.1. Introduction
- 14.1.1. Key Findings
- 14.2. Market Value Forecast By Device Type, 2017 - 2031
- 14.2.1. Electroencephalogram (EEG) Systems
- 14.2.2. Magnetic Resonance Imaging (MRI) Systems
- 14.2.3. Computed Tomography (CT) Scanner
- 14.2.4. Position emission tomography (PET) System
- 14.2.5. Ultrasound Imaging Systems
- 14.2.6. Others
- 14.3. Market Value Forecast By Indication, 2017 - 2031
- 14.3.1. Neurodegenerative Disease
- 14.3.2. Epilepsy
- 14.3.3. Stroke
- 14.3.4. Others
- 14.4. Market Value Forecast By End-user, 2017 - 2031
- 14.4.1. Hospitals and Surgery Centers
- 14.4.2. Neurology Centers
- 14.4.3. Ambulatory Care Centers
- 14.4.4. Diagnostic Laboratories & Imaging Centers
- 14.4.5. Research Laboratories & Academic Institutes
- 14.5. Market Value Forecast By Country, 2017 - 2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Device Type
- 14.6.2. By Indication
- 14.6.3. By End-user
- 14.6.4. By Country
- 15. Competition Landscape
- 15.1. Market Player – Competition Matrix (By Tier and Size of companies)
- 15.2. Market Share Analysis By Company (2022)
- 15.3. Company Profiles
- 15.3.1. GE Healthcare
- 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.1.2. Product Portfolio
- 15.3.1.3. Financial Overview
- 15.3.1.4. SWOT Analysis
- 15.3.1.5. Strategic Overview
- 15.3.2. Neurosoft
- 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.2.2. Product Portfolio
- 15.3.2.3. Financial Overview
- 15.3.2.4. SWOT Analysis
- 15.3.2.5. Strategic Overview
- 15.3.3. Canon Medical Systems Corporation (Canon, Inc.)
- 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.3.2. Product Portfolio
- 15.3.3.3. Financial Overview
- 15.3.3.4. SWOT Analysis
- 15.3.3.5. Strategic Overview
- 15.3.4. Fujifilm Holding Corporation
- 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.4.2. Product Portfolio
- 15.3.4.3. Financial Overview
- 15.3.4.4. SWOT Analysis
- 15.3.4.5. Strategic Overview
- 15.3.5. Koninklijke Philips N.V.
- 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.5.2. Product Portfolio
- 15.3.5.3. Financial Overview
- 15.3.5.4. SWOT Analysis
- 15.3.5.5. Strategic Overview
- 15.3.6. Siemens Healthineers AG
- 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.6.2. Product Portfolio
- 15.3.6.3. Financial Overview
- 15.3.6.4. SWOT Analysis
- 15.3.6.5. Strategic Overview
- 15.3.7. Shimadzu Corporation
- 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.7.2. Product Portfolio
- 15.3.7.3. Financial Overview
- 15.3.7.4. SWOT Analysis
- 15.3.7.5. Strategic Overview
- 15.3.8. United Imaging Healthcare Co., Ltd.
- 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.8.2. Product Portfolio
- 15.3.8.3. Financial Overview
- 15.3.8.4. SWOT Analysis
- 15.3.8.5. Strategic Overview
- 15.3.9. Hologic, Inc.
- 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.9.2. Product Portfolio
- 15.3.9.3. Financial Overview
- 15.3.9.4. SWOT Analysis
- 15.3.9.5. Strategic Overview
- 15.3.10. Esaote SpA
- 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.10.2. Product Portfolio
- 15.3.10.3. Financial Overview
- 15.3.10.4. SWOT Analysis
- 15.3.10.5. Strategic Overview
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook